These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 176332)
1. Localization of myocardial disorders other than infarction with 99mTc-labeled phosphate agents. Perez LA; Hayt DB; Freeman LM J Nucl Med; 1976 Apr; 17(4):241-6. PubMed ID: 176332 [TBL] [Abstract][Full Text] [Related]
2. Acute myocardial infarction imaged with 99mTc-stannous pyrophosphate and 201Tl: a clinical evaluation. Parkey RW; Bonte FJ; Stokely EM; Lewis SE; Graham KD; Buja LM; Willerson JT J Nucl Med; 1976 Sep; 17(9):771-9. PubMed ID: 182930 [TBL] [Abstract][Full Text] [Related]
3. Myocardial scintigraphy with 99mTc-pyrophosphate in 150 coronary care unit patients. Lessem J; Johansson BW; Nosslin B Eur J Cardiol; 1976 Dec; 4(4):453-9. PubMed ID: 187427 [TBL] [Abstract][Full Text] [Related]
4. The significance of calcific valvular heart disease in Tc-99m pyrophosphate myocardial infarction scanning: radiographic, scintigraphic, and pathological correlation. Jengo JA; Mena I; Joe SH; Criley JM J Nucl Med; 1977 Aug; 18(8):776-80. PubMed ID: 194933 [TBL] [Abstract][Full Text] [Related]
5. Localization of 99mTc-Sn-pyrophosphate in left ventricular aneurysms. Kelly RJ; Cowan RJ; Maynard CD; Headley RN; Kahl FR J Nucl Med; 1977 Apr; 18(4):342-5. PubMed ID: 191579 [TBL] [Abstract][Full Text] [Related]
6. Technetium pyrophosphate scanning in the detection of acute myocardial infarction: clinical experience. Ko P; Kostuk WJ; Deatrich D Can Med Assoc J; 1977 Feb; 116(3):260-3. PubMed ID: 189887 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium. Dewanjee MK; Kahn PC J Nucl Med; 1976 Jul; 17(7):639-46. PubMed ID: 178842 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of myocardial revascularization utilizing Tc-99m pyrophosphate. Liddicoat JE; Bekassy SM; Johnson PC; Ajmani SK; DeBakey ME Cardiovasc Res Cent Bull; 1974; 13(1):8-14. PubMed ID: 4377117 [TBL] [Abstract][Full Text] [Related]
9. [Negative and positive imaging of myocardial infarct]. Kahn P; Aldor E; Blazek G; Heeger H Nuklearmedizin; 1977 Apr; 16(2):63-7. PubMed ID: 876843 [TBL] [Abstract][Full Text] [Related]
17. Detection and size estimation of acute myocardial infarction using 99Tc-glucoheptonate. Rossman DJ; Rouleau J; Strauss HW; Pitt B J Nucl Med; 1975 Nov; 16(11):980-5. PubMed ID: 1185277 [TBL] [Abstract][Full Text] [Related]
18. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676 [TBL] [Abstract][Full Text] [Related]
19. [Physiopathologic introduction to anesthesia and resuscitation of the vascular patient]. Coriat P J Mal Vasc; 1998 Feb; 23(1):35-40. PubMed ID: 9551351 [TBL] [Abstract][Full Text] [Related]
20. Rat model for acute myocardial infarction: application to technetium-labeled glucoheptonate, tetracycline, and polyphosphate. Adler N; Camin LL; Shulkin P J Nucl Med; 1976 Mar; 17(3):203-7. PubMed ID: 1249630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]